Save
Upgrade to remove ads
Busy. Please wait.
Log in with Clever
or

show password
Forgot Password?

Don't have an account?  Sign up 
Sign up using Clever
or

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
focusNode
Didn't know it?
click below
 
Knew it?
click below
Don't Know
Remaining cards (0)
Know
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

WEEK 7:

Obesity 2- control of appetite:

QuestionAnswer
difference between hunger and appetite desire/need for food but appetite is desire to eat food
food intake affected by (2) hunger and appetite
satiation feeling of fullness that terminates meal
satiety feeling of repletion that inhibits further meals
what controls food intake hypothalamus
hypothalamus-arcuate nucleus (ARC) has role in integration of appetite signals where region of brain is not protected by BBB so allows gut hormones to pass into brain
pathway explaining food intake (S7)**
POMC undergoes posttranslational modification
POMC undergoes posttranslational modification to generate (2) melanocortins and AgRP
melanocortins act on melanocortin receptors
AgRP endogenous antagonist of melanocortin-4-receptor
gut distension leads to release of what cells from enteroendocrine cells (6) cholecystokinin (CCK) glucagon-like peptide-1 (GLP-1) Oxyntomodulin peptide YY (PYY3–36) apolipoprotein A-IV enterostatin
leptin Peptide hormone secreted from adipose tissue
role of leptin decrease food intake leading to decreased leptin levels
the effects of leptin is reversed by refeeding or insulin
production of leptin correlates with amount of adipose tissue (energy stores)
mutations in leptin leads to severe obesity
when leptin is transported into the brain what does it do (3) inhibits NPY AgRP release activates the POMC/CART neurons switch from appetite stimulation to appetite suppression
what does leptin do to NPY AgRP release once in the brain inhibits them
what does leptin do to POMC/CART neurons once in the brain activates them
insulin is increased when positive energy balance
insulin is decreased when negative energy balance
insulin cross BBB through receptor mediated process
insulin decrease intake and body weight through actions on ARC
ghrelin produced from GIT
ghrelin secreted on anticipation of food
ghrelin acts centrally at ARC or brain stem to stimulate food intake through NPY and AgRP
ghrelin stimulates food intake through NPY and AgRP
ghrelin is responsible for being hungry at certain times of day (stimulates hunger)
ghrelin levels peak when before meal
what happens to ghrelin levels if individual restricts energy intake to lose weight ghrelin levels increases
PYY secreted from distal GIT dependent on nutrient intake (protein> fat or CHO)
PYY stimulated by (3) CCK, gastric acid and bile
PYY1-36 cleaved to PYY3-36
PYY1-36 cleaved to PYY3-36 acts at NPY Y2 receptor
effect of PYY inhibits food intake possibly through vagal inputs (decreases food intake in lean and obese - no resistance)
PYY levels stay elevated for how long 12 hours post meal
CCK (cholecystokinin) released from duodenum and jejunum in response to FAs
CCK acts on receptors on vagal nerve
CCK possibly crosses BBB
CCK effect inhibits food intake
appetite linked to reward processes in brain (3) Opioid receptors (endorphins) Cannabinoid receptors Dopamine
feeding is associated with dopamine release in dorsal striatum
feeding is associated with dopamine release where dorsal striatum
degree of pleasure correlates with amount of dopamine released
bupropion dopamine reuptake inhibitor in weight loss
prescription only medicines (3) Orlistat Liraglutide Semaglutide
orlistat effect inhibits gastric and pancreatic lipase with minimal absorption having 30% inhibition of lipases at normal therapeutic doses (200kcal lost/day)
orlistat has to be taken when before each main meal
side effects of orlistat steatorrhea and reduced absorption of fat (therefore need to monitor fat soluble vitamin status and possible need for supplements)
BMI has to be >30kg/m2 or >28kg/m2 if other risk factors eg type 2 diabetes
drugs should only be continued after 12 weeks if weight loss exceeds 5%
treatment >12 months should only be done after discussion potential benefits and risks with patient
dose orlistat 120mg taken IMMEDIATELY before or during 1 hour after each main meal (max 360mg daily)
when should orlistat dose be missed if meal contains no fat
OTC orlistat dose 60mg tds for max 6 months combined with reduced fat diet, BMI >28 and review after 12 weeks where dietary approaches and physical activity should be tried
mysimba combination fo naltrexone and bupropion
mysimba has effects on reward pathway (similar efficacy as orlistat)
what does NICE think of mysimba not recommended- cost effectiveness not clear
sibutramine combined NA and 5HT uptake inhibitor
effect of sibutramine appetite suppressant
use of sibutramine no longer used as increased blood pressure and heart rate
rimonabant (acomplia) CB1 receptor antagonist Review found that benefits do not outweigh the risks
Phentermine (USA not licensed in UK as increases catecholamine levels in brain and peripheral effects (increase HR, BP, palpitation)
liraglutide (saxenda/victoza brand name) mode of action Binds to, and activates, the GLP-1 receptor to increase insulin secretion, suppresses glucagon secretion, and slows gastric emptying
liraglutide (saxenda/victoza brand name) acts on brains subcortical areas to increase satiety
how often is liraglutide (saxenda/victoza brand name) used administered daily
semaglutide (wegovy/ozempic brand name) mode of action Binds to, and activates, the GLP-1 (glucagon-like peptide-1) receptor to increase insulin secretion, suppress glucagon secretion, and slow gastric emptying
semaglutide (wegovy/ozempic brand name) used administered once a week
compare semaglutide and liraglutide semiglutide more effective than liraglutide as it has longer duration of action
semiglutide recommended as option for weight management alongside reduced calorie diet and increased physical activity
tirzepatide (mounjaro) mode of action Tirzepatide activates GIP and GLP‑1 receptors. These appetite-related signals act in the brain to increase fullness and reduce hunger and food cravings; it also slows gastric emptying, particularly early in treatment.
Created by: 22tango
Popular Medical sets

 

 



Voices

Use these flashcards to help memorize information. Look at the large card and try to recall what is on the other side. Then click the card to flip it. If you knew the answer, click the green Know box. Otherwise, click the red Don't know box.

When you've placed seven or more cards in the Don't know box, click "retry" to try those cards again.

If you've accidentally put the card in the wrong box, just click on the card to take it out of the box.

You can also use your keyboard to move the cards as follows:

If you are logged in to your account, this website will remember which cards you know and don't know so that they are in the same box the next time you log in.

When you need a break, try one of the other activities listed below the flashcards like Matching, Snowman, or Hungry Bug. Although it may feel like you're playing a game, your brain is still making more connections with the information to help you out.

To see how well you know the information, try the Quiz or Test activity.

Pass complete!
"Know" box contains:
Time elapsed:
Retries:
restart all cards